NCT06667622View on ClinicalTrials.gov

Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 29, 2024

Primary Completion Date

January 10, 2026

Study Completion Date

July 20, 2026

Conditions
Chemoradiotherapy
Interventions
DRUG

sodium glycididazole

Sodium glycididazole is intravenously infused at a dose of 800mg at 60 min before radiotherapy and used on Mondays, Wednesdays and Fridays during radiotherapy.

Trial Locations (1)

100021

RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors
lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER